JKJohnson
Curriculum Vitae
Jennifer K. (Kristie) Johnson, Ph.D., D(ABMM)
Associate Professor, Department of Pathology
University of MarylandSchool of Medicine
DateOctober 7, 2016
Contact Information
Business Address: 22 South Greene Street, Room N2W50B
Baltimore, Maryland 21201
Office Phone Number:(410) 328-6698
Laboratory Phone Number:(410) 706-7062
Fax:(410) 706-8414
Beeper:(410) 382-2337 x3977
Email:
Education
1992-1996B.S. Degree in Biology, minor in Chemistry, Salisbury State University
Salisbury, Maryland
1996-2002Ph.D. in Microbiology and Immunology, University of Maryland, Baltimore
Thesis: Analysis of the Specificity and Genetics of Antibodies to Soman.
Mentor: David E. Lenz, Ph.D.
1998-2000Rapid Transition Training Program, Categorical in Microbiology University of Maryland School of Medicine
Department of Medical and Research Technology
Postgraduate Education and Training
2003-2006Postdoctoral Fellowship, Department of Pathology, University of Maryland School of Medicine
Mentor: Richard A. Venezia, Ph.D., D(ABMM)
Certifications
1998-PresentTechnologist in Microbiology, American Society of Clinical Pathology Board of Certification
2010-PresentDiplomate in Public Health and Medical Microbiology, The American Boardof Medical Microbiology of the American Academy of Microbiology
Employment History
Academic Appointments
2006-2012Assistant Professor, Department of Pathology, University of Maryland School of Medicine (Primary appointment)
2007-PresentVA Research Health Scientist (WOC),Baltimore Veterans Administration
2011-2012Assistant Professor,Department of Epidemiology and Public HealthUniversity of MarylandSchool of Medicine (Secondary appointment)
2012-PresentAssociate Professor, Department of Pathology, University of Maryland School of Medicine (Primary appointment)
2012-PresentAssociate Professor,Department of Epidemiology and Public HealthUniversity of MarylandSchool of Medicine (Secondary appointment)
2013-PresentAssociate Professor,Department of Microbiology and ImmunologyUniversity of MarylandSchool of Medicine (Secondary appointment)
Other Employment
1996-1997 ORISE Fellow, Toxicology Division, Toxicology Evaluation Branch
US Army Center for HealthPromotion and Preventive Medicine
Aberdeen Proving Ground-Edgewood Area, Maryland 21010
1998Graduate Research Assistant, Department of Oral and Craniofacial Sciences
School of Dentistry
University of Maryland, Baltimore
1998-2002ORISE Fellow, Pharmacology Division, Biochemical Pharmacology Branch
US Army Medical Research Institute of Chemical Defense
Aberdeen Proving Ground-Edgewood Area, Maryland 21010
2003Scientist - Section Head
Rapid Diagnostics: Bioterrorism Response Section
MarylandDepartment of Health and Mental Hygiene
Professional Society Memberships
1997-Present National and Maryland Branch of American Society of Microbiology
2006-Present Pan American Society of Clinical Virology
2008-Present Association of Molecular Pathology
2013-PresentSociety of Healthcare Epidemiology
Honors and Awards
1999Excellence in Microbiology Award, University of Maryland School of Medicine
Department of Medical and Research Technology
2000-2001 Merit Scholarship Award, University of Maryland Dental School
2000-2002 NIH National Research Service Award Training Program
2011Richard S. Schwalbe Award, American Society of Microbiology, Maryland Branch
Clinical Activities
2006-2014Associate Director of Clinical Microbiology and Virology Laboratories
Laboratories of Pathology, University of Maryland Medical Center
- Clinical Microbiology Seminar Series
- Pace Lectures for Laboratory Staff
- Physician Consults
- Patient Rounds
- Clinical Plate Rounds
- Member
- Pandemic Steering Committee
- Executive Infection Control Committee
- Antimicrobial Subcommittee
- Ebola Steering Committee
- Moved all protocols to electronic and placed on share drive for all employees to view while working at the bench.
- Molecular Detection
- MRSA
- Influenza and RSV
- Respiratory viruses (10)
- Enterovirus
- Clostridium difficile
- PNA-FISH from positive blood cultures
- Surveillance
- MRSA
- Acinetobacter baumannii
- Carbapenem-Resistant Enterobacteriaceae
- Rapid Detection from Blood Cultures
- Antibiotic Resistance
- Fluconazole susceptibility in Candida species
- Carbapenemase detection in Enterobacteriaceae
2014-2015Interim Director of Clinical Microbiology and Virology Laboratories. Laboratories of Pathology, University of Maryland Medical Center
2014-2015Interim Director of Clinical Microbiology, University of Maryland Pathology Associates
2014-PresentCo-Director of Bio-containment Unit, Laboratory,University of Maryland Medical Center
2015-PresentDirector of Clinical Microbiology, University of Maryland Medical Center
2015-PresentDirector of Clinical Microbiology, University of Maryland Pathology Associates
Administrative Service
Institutional Service
2006-2014Associate Director of Clinical Microbiology and Virology Laboratories
Laboratories of Pathology, University of Maryland Medical Center
2006-PresentMember, UMMC Infection Control Executive Committee
2008-2010Associate Member, Graduate Faculty
2009-PresentMember, UMMC Pandemic Steering Committee
2010-Present Regular Member, Graduate Faculty
2011-PresentMember, Host Defenses and Infectious Diseases Committee, University of Maryland School of Medicine
2011-PresentInterviewer, Office of Admissions, University of Maryland School of Medicine
2011-PresentMember, UMMC Antimicrobial Subcommittee of the P&T Committee
2011-PresentMember, Pathology Residency Committee
2011Judge, Medical Student Research Day
2013-PresentMember, Clinical Competency Committee, Department of Pathology
2014-2015Interim Directorof Clinical Microbiology and Virology Laboratories
Laboratories of Pathology, University of Maryland Medical Center
2014-2015Interim Director of Clinical Microbiology, University of Maryland Pathology Associates
2014-PresentMember, UMMC Strategic Steering Committee-Ebola Preparation Plan
2014-PresentMember, UMMC Laboratory Services Committee-Ebola Preparation Plan
2014-PresentCo-Director of Bio-containment Unit, Laboratory,University of Maryland Medical Center
2015-PresentMember, Quality Assurance Oversight Committee, University of Maryland Medical Center, Laboratories of Pathology
2015-PresentMember, Institutional BioSafety Committee, University of Maryland, Baltimore
2016-PresentMember, UMMC Laboratory Utilization Committee
2015-PresentDirector of Clinical Microbiology, University of Maryland Medical Center
2015-PresentDirector of Clinical Microbiology, University of Maryland Pathology Associates
Local Service
2009 Member of ASM Division C Chair nomination Committee
2010-2014 Judge for J. Howard Brown Award given by the Maryland Branch ASM
2010-PresentMember, Maryland MDRO Collaborative
2011-2014Board of Directors, American Society of Microbiology, Maryland Branch
2012-2013President, American Society of Microbiology, Maryland Branch
National Service
2008-PresentReviewer, Diagnostic Microbiology and Infectious Diseases(1x/year)
2010-PresentReviewer, European Journal of Clinical Microbiology and Infectious Diseases(1x/year)
2011-PresentReviewer, Journal of Medical Microbiology(1x/year)
2011-PresentReviewer, Journal of Clinical Microbiology(3x/year)
2011-PresentReviewer, Journal of Microbiological Methods(0-1x/year)
2011-PresentReviewer, American Journal of Infection Control(0-1x/year)
2012-PresentReviewer, PLOS ONE(2x/year)
2012-PresentMember, Clinical Microbiology Mentoring Committee of the Professional Practice Committee, American Society of Microbiology (Term until 2017)
2012-2014Member, The American Boardof Medical Microbiology (ABMM) Validation Committee
2012American Society of Microbiology Career Session (June 16, 2012)
2012-PresentReviewer, Infections(0-1x/year)
2012-PresentReviewer, Journal of Antimicrobial Chemotherapy(1x/year)
2014-PresentAmerican Society of Microbiology Division C Finance Committee
2014Member, Expert Panel, UPMC Center for Health Security, Improving the Odds: What government can do to encourage the development of commercially viable infectious disease diagnostics.
2014-PresentMember, The American Boardof Medical Microbiology (ABMM) Item Committee
2014American Society of Microbiology Convener for Diagnostic Microbiology and Epidemiology Session for the 114th General Meeting May 18, 2014: The Evolving Role on Active Surveillance for MDROs for Infection Prevention: The Impact of New Landmark Studies upon the Clinical Microbiologist.
2014-PresentReviewer, Annals of Clinical Microbiology and Antimicrobials(0-1x/year)
2015-PresentMember, Editorial Board, Journal of Clinical Microbiology (2017)
2015-PresentMember, Methods Application and Interpretation Working Group for the Subcommittee on Antimicrobial Susceptibility Testing, Clinical Laboratory Standards Institute (CLSI)
2016-PresentMember, Editorial Board, Journal of Applied Laboratory Medicine(2019)
2016-PresentReviewer, Journal of Applied Laboratory Medicine(2x/year)
2016-PresentMember, Carbapenemase Inactivation Method Working Group, Clinical laboratory Standards Institute (CLSI)
2016American Society of Microbiology Convener for Clinical Science and Epidemiology Symposium for the ASM Microbe 2016 Meeting June 18, 2016: Guess the Bacterial Resistance Mechanism
2016American Society of Microbiology Convener for Clinical Science and Epidemiology Symposium for the ASM Microbe 2016 Meeting June 19, 2016: Optimal Use of Rapid Diagnostics in the Clinical Microbiology Laboratory for Quality Improvement and Clinical Care
2016Study Section Member, Defense Medical Research and Development Program
2016-presentScientific Lead, CDC/ASM Laboratory Medicine Best Practices committee on Bloodstream Infections
2016-presentMember, Association of Public Health Laboratories (APHL) Biosafety and Biosecurity Partners Forum (recently appointed by SHEA)
Teaching Service
Prior to Faculty Appointment
1998Laboratory Assistant, Pathogenic Microbiology,
3rd year Medical Technology Students- 6 contact hours/week
Department of Medical and Research Technology, University of MarylandSchool of Medicine
1998Lecturer
Pathogenic Microbiology
3rd year Medical Technology Students- 4 contact hours
Department of Medical and Research Technology, University of Maryland School of Medicine
1999-2001Laboratory Assistant
Dental Microbiology
2nd year Dental Students – 1 contact hour/week
University of MarylandDental School
Faculty Appointment
Basic Sciences
2004-PresentPreceptor, Laboratory Small Group
Host Defenses and Infectious Diseases Laboratory
Second year Medical Students
40 students/year, 6 hours/year
University of MarylandSchool of Medicine
2005-2007Lecturer
Seminars in Biological Terrorism
Smallpox
6-8 students, 2 hours/year
Department of Pathology, University of MarylandSchool of Medicine
2006-PresentMember of Thesis/Dissertation Committee
Department of Epidemiology and Preventive Medicine, University of Maryland School of Medicine
7 graduate students, 20 hours/year per mentee
2007Lecturer
Emerging Infections (NURS 418)
Molecular Epidemiology
20 nursing students, 2 hours/year
University of MarylandSchool of Nursing
2007-2013Research Mentor
Molecular Epidemiology Practicum
Epidemiology Ph.D. Graduate Students
Molecular Epidemiology Track, University of Maryland Graduate School
2 students/ 20 hours
2009-PresentLecturer
Clinical Virology (MEDT 471)
15 students, 6 hours/year
Department of Medical and Research Technology,University of MarylandSchool of Medicine
2009-PresentMember of Thesis/Dissertation Committee
Department of Medical and Research Technology, University of Maryland School of Medicine
1 graduate student, 20 hours/year per mentee
2010Lecturer
Pathogenic Microbiology (MEDT 472)
12 students, 4 hours/year
Department of Medical and Research Technology,University of MarylandSchool of Medicine
2010-PresentPrimary Mentor
Department of Epidemiology and Preventive Medicine, University of Maryland School of Medicine
3 graduate students, 104 hours/year per mentee
2011-PresentLecturer, Bacteriology Laboratory I, II, and III
Host Defenses and Infectious Diseases Laboratory
Second year Medical Students
160 students/year, 6 hours/year
University of MarylandSchool of Medicine
2015-PresentLecturer, Principles of Pharmacology
University of Maryland, Baltimore
School of Medicine
Department of Pharmacology
10 graduate students, 6 hours/year
Clinical Sciences(Fellows and Residents)
2003-PresentMedical Microbiology Plate Rounds
Clinical Microbiology Laboratory
1st and 2nd year Infectious Disease Fellows, 3rd or 4th year Medical Students, Pathology Residents and Attendings
12-15 fellows per year, 2-3 medical students, 1 pathology resident, 1-2 faculty members/year
78 contact hours/year
Department of Pathology, University of Maryland Medical Center
2006-PresentMentor
Medical Microbiology Rotations
5-6 pathology residents, 1-2 medical students
2 hours/ rotation
Microbiology Laboratory, University of Maryland Medical Center
2006-PresentMedical Microbiology Lectures
Pathology Residents
10-12 residents, 8 contact hours
Department of Pathology,University of Maryland Medical Center
2014-PresentMedical Microbiology Rotations
Infectious Disease Fellows
10-12 fellows/year, 10 contact hours
Department of Medicine, Division of Infectious Diseases, University of Maryland Medical Center
Students/Residents/Fellows Mentored
*Indicates that I serve(d) as the primary mentor
Training period / Student / Mentor / Current Position2006-2009 / Kristen Kriesel, MS, Ph.D. / Ph.D. Student
Thesis Committee Member / STD MIS Data Manager
Virginia State Health Department
2007-2008 / Kerri Thom, MD, MS / Master Student Thesis Committee Member / Assistant Professor, University of Maryland, School of Medicine
2007 / Simone Shurland, Ph.D / Ph.D. Student
Laboratory Rotation / Microbiologist, FDA
Bethesda, Maryland
2007-2008 / Simone Shurland, Ph.D / Ph.D. Student
Thesis Committee Member / Microbiologist, FDA
Bethesda, Maryland
2007-2009 / Marin Schweizer, Ph.D / Ph.D. Student
Thesis Committee Member / Research Associate, University of Iowa,
School of Medicine
2009 / Albert Lee / Ph.D. Student
Laboratory Rotation / Ph.D. Student, UMB
2009-2010 / Anne Koehne de Gonzalez / Medical Student / Pathology Resident,
Columbia University Medical Center, New York City
2009 / Angela Stancil* / Master Student Laboratory Roatation / Biology High School Teacher
2009 / Adebola Ajao / Ph.D. Student
Thesis Committee Member / Microbiologist, FDA
Bethesda, Maryland
2009 / Monica Smith / Master Student Thesis Committee Member / Becton Dickinson
Sparks, MD
2009-2011 / Angela Stancil* / Master Student Thesis Committee Member / Biology High School Teacher
2010 / Aaron Hess / Medical Student / Anesthesiology Resident, University of Wisconsin-Madison
2010 / Jennifer Siu / Medical Student
Summer Rotation / MD/MPH Student, UMB
2010 / Marin Schweizer, Ph.D. / Research Associate / Research Associate, University of Iowa,
School of Medicine
2011-2012 / Aaron Hess / MD/Ph.D. Student / Anesthesiology Resident, University of Wisconsin-Madison
2012-2012 / Mallory Boutin* / Capstone Mentor / Research Associate, University of San Diego
2011-2014 / Tracy Hazen, Ph.D. / Postdoctoral Fellow / UMB Research Associate
2012-2014 / Chris Pepin* / Student Laboratory Rotation / Ph.D. Student, UMB
2013-2014 / Shana Burrowes / Student Laboratory Rotation / Ph.D. Student, UMB
2013-2014 / Jackie Bork* / Research Elective / Clinical Instructor, JHU
2015-2016 / Emily Stucke / Student Laboratory Rotation / Ph.D. Student, UMB
2015-2016 / UM College Park Bio-Engineering Group / Clinical Advisor, Student Capstone Project / Bio-Engineering Undergraduate Students
2016-Present / Eric Kong / Ph.D. Student
Thesis Committee Member / Ph.D. Student, UMB
2016-Present / Sarah Jackson / Ph.D. Student
Thesis Committee Member / Ph.D. Student, UMB
2016-Present / Natalia Blanco Herrera, Ph.D. / Postdoctoral Fellow / Postdoctoral Fellow, UMB
Grant Support
Active Grants
10/01/11 - 03/31/17Role: Co-Investigator (10%) PI: M.C. Roghmann
(NCE)“Metagenomic Studies of MRSA Colonization”
Veterans Health Administration CSR&D
Total Direct Costs: $508,781
Total Indirect Costs: $0
Direct laboratory work and personnel and review, interpret, analyze, and publish data.
07/01/12 - 12/31/17 Role: Co-Investigator (10%) PI: M.C. Roghmann
(NCE)“Modifying Isolation Precautions for MRSA in Non-acute Care
Settings”
VA Merit Grant Health Services R&D
RII10-154
Total Direct Costs: $1,035,459
Total Indirect Costs: $0
Direct laboratory work and personnel and review, interpret, analyze, and publish data.
04/01/14 - 03/31/16Role: Co-Investigator (5%)PI: K. Kotloff
(NCE)“Incidence, Mode of Transmission, and Sequelae of Community-Acquired Methicillin Resistant Staphylococcus aureus Infection in the Neonatal Intensive Care Unit and the Effectiveness of Decolonization”
NIH VTEU
Direct Costs: $822,310
Direct laboratory work and personnel and review, interpret, analyze, and publish data.
08/01/15 - 07/31/19Role: Co-Investigator (5%) PI: Thom
Removing barriers to hand hygiene and glove compliance: Evaluation of two novel time-efficient interventions
Agency for Healthcare Research and Quality
R01 HS024108-01
Direct and Indirect cost:$1,571,807
Direct laboratory work and personnel and review, interpret, analyze, and publish data.
09/30/15 - 12/29/16Role: Principal Investigator (2%)
Sentinel Site Surveillance for AR Organisms II
CDC-SHEPheRD Program Contract RFTOP 2015-008
Direct Cost: $78,500
Indirect Cost: $20,500
9/15/15-9/14/17Role: Co-investigator (10%)PI: Cross
Development of a multivalent vaccine to prevent invasive infections and colonization with Klebsiella pneumoniae and Pseudomonas aeruginosa.
Nosocimial Vaccine Company
Total Direct Costs: $3, 239,933
Provide bacterial strains and expertise in Klebsiella pneumoniae and Pseudomonas aeruginosa.
09/30/15 - 09/29/18 Role: Co-investigator(10%) PI: Harris
Epicenters for the Prevention of Healthcare Associated Infections (HAI) - Cycle II
Centers for Disease Control
1U54CK0000450-01
Direct and Indirect cost:$1,432,368
Direct laboratory work and personnel and review, interpret, analyze, and publish data.
10/01/15-3/31/18Role: Co-investigator (10%) PI: Harris
“Does Universal Glove and Gown use decrease carbapenem-resistance Gram-negative bacteria”
AHRQ R18 HS024045
Total Directs: $770,800
Total Indirects: $417,310
Direct laboratory work and personnel and review, interpret, analyze, and publish data.
03/01/16-02/28/18Role: Co-Investigator (10%) PI: M.C. Roghmann
“Transmission of Antibiotic-resistant Gram-negative Bacteria in Nursing Homes.”
National Institute of Allergy and Infectious Diseases
R03-A1-122223
Total Direct Costs: $153,000
Direct laboratory work and personnel and review, interpret, analyze, and publish data.
09/01/2016-08/31-17Role:Principal Investigator (2%)
“Understanding the workflow of positive blood cultures from sampling to results.”
Q-Linea
Direct Costs: $9,999
8/10/16-07/31/2020Role: Co-Investigator (10%) PI: Harris
“Epidemiology of CRE and MRSA transmission: patient and organism factors”
NIH National Institute of Allergy and Infectious Diseases
1R01AL121146-01
Total Directs: $1,800,599
Direct laboratory work and personnel and review, interpret, analyze, and publish data.
09/15/16-11/14/17Role: Co-Principal Investigator (10%)
“Identification of Microbial disruption indices (MDI) predictive of colonization and dominance by multi-drug resistant Pseudomonas aeruginosa. “
Centers for Disease Control and Prevention
BAA 2016-N-17812
Total Costs: $459,721
Total Indirects: $606,837
Pending Grants
10/01/16-09/30/17Role:Principal Investigator (2%)
“A Clinical Evaluation of a Gastrointestinal Infection panel Assay system (ACEGIS)”
Applied BioCode
Total Cost: $100,000
04/1/17-03/31/22Role: Sub-award PI (10%)PI: Bachman
“Integrated modeling of Klebsiella pneumoniae infections based on bacterial genotype, patient factors and colonization status”
NIH R01 AI 125307 01 A1
NIH-DHHS-US
Total Cost: $312,770 sub award
TotalCost: $2,713,340
Completed Grants
09/01/05 - 07/31/12Role: Investigator/Scholar (75%)PI: A.R. Shuldiner
“Transmission of Plasmid Mediated AmpC β-lactamases”
University of Maryland Multidisciplinary Research Career Development Program (MCRDP)
NIH K12RR023250
Total Direct Costs: $12,309,704
06/01/07 - 11/01/07Role: PI (5%)
“Culture results for patients with positive blood cultures”
AdvanDx
Total Direct Costs: $3,000
08/01/07 - 07/31/08Role: PI (75%)
“Understanding Resistance Mechanisms in Fecal Microorganisms”
University of Maryland GCRC
Total Direct Costs: $10,000
09/30/07 - 09/29/08Role: Co-Investigator (in kind/mentor)PI: K Kreisel
“Risk Factors and Outcomes of Infections Due to USA300 Methicillin Resistant Staphylococcus aureus”
CDC R36 Grant for Public Health Research Dissertation
Program Announcement PAR-07-231
Total Direct Costs: $35,000
10/22/07 - 12/31/07Role: PI (15%)
“BacLite for the detection of MRSA”
3M Medical Diagnostics
Total Direct Costs: $40,000
07/01/08 - 06/30/09Role: Co-PI (5%)PI: R. Venezia
“Detection of MRSA from Blood Cultures”
Microphage
Total Direct Costs: $21,000
02/01/10 - 02/01/11Role: PI (5%)
“Clinical Validation of the Molecular-based BD GeneOhm VanR assay for the presumptive identification of vancomycin resistant Enterococci in perianal and/or rectal specimens”
Becton Dickinson
Total Direct Costs: $75,000
04/15/10 - 07/31/11Role: Site PI(in kind/mentor)PI: M. Schweizer
“Linezolid Therapy and Outcomes in Patients with Post-Influenza Staphylococcus aureus Pneumonia, Controlling for Patient, Pathogen, and Treatment Characteristics”
Pfizer
06/01/10 - 11/30/13Role: Co-Investigator (5%)PI: A.D. Harris
“Epidemiology of emerging pathogens among hospitalized patients”
2R01AI060859-05 Renewal
Direct Costs: $900,000
Indirect Costs: $436,500
Total Direct Costs: $100,000
06/28/10 - 12/01/11 Role: Co-Investigator (5%)PI: K Thom
Maryland MDR Acinetobacter Prevalence Survey
3U50CI000485 Maryland Department of Health and Mental Hygiene
Direct Costs: $178,000
07/26/10 - 07/25/12Role: Co-Investigator (5%) PI: J. Furuno
“Using Nursing Home Antibiograms to Improve Antibiotic Prescribing and Delivery”
AHRQ HHSA290200600020I
Direct Costs:$621,298
08/16/10 - 08/14/13Role: Co-Investigator (5%)PI: A.D. Harris
“Novel Interventions to Decrease Healthcare Associated Infections”
AHRQ (Choice)
Direct Costs: $1,064,827
03/01/11 - 02/28/15Role: Co-Investigator (5%)PI: M.C. Roghmann
“Human Microbiome and Healthcare-associated Infections”
National Institutes of Health, National Institute of Allergy and Infectious Diseases
R01
Total Direct Costs: $1,134,557
Total Indirect Costs: $567,279
08/01/11 - 07/31/14Role: Co-Investigator (10%)PI: M.C. Roghmann
“Modifying Isolation Precautions for MRSA in Long Care Setting”
Agency for Healthcare Research and Quality
Total Direct Costs: $1,012,297
Total Indirect Costs: $338,262
10/01/11 - 09/30/12Role: PI (no salary for PI)
“Drug Resistant Gram Negative Microorganisms in VA Long Term Care Facilities”
Baltimore Research and Education Foundation, Inc.
Total Direct Cost: $19,500
01/31/12 - 02/01/14Role: PI (10%)
“A novel agent to decrease contamination of hospital scrubs”
BioMed Protect Inc.
Total Direct Costs: $80, 845
Total Indirect Costs: $43, 252
The contract is with the UMB SOM Center for Clinical Trials.
08/01/12 - 07/31/13Role: Principal Investigator (2%)